Showing results (1-10 of 150) with videos related to
Sort By:
Pageof 15
Seminars in Arthritis and Rheumatism|October 30, 2010
Drug monitoring in systemic lupus erythematosus: a systematic reviewGabriela Schmajuk, Jinoos YazdanyRheumatology International|August 31, 2017
Leveraging the electronic health record to improve quality and safety in rheumatologyGabriela Schmajuk, Jinoos YazdanyCurrent Osteoporosis Reports|November 30, 2019
Quality Measures and Quality Improvement Initiatives in Osteoporosis-an UpdateS French, S Choden, Gabriela SchmajukCurrent Opinion in Rheumatology|December 13, 2016
A new era of quality measurement in rheumatology: electronic clinical quality measures and national registriesChris Tonner, Gabriela Schmajuk, Jinoos YazdanyArthritis Care & Research|March 18, 2015
Use and Spending for Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Among US Medicare BeneficiariesJinoos Yazdany, Chris Tonner, Gabriela SchmajukPatient Preference and Adherence|October 9, 2023
Peer Support in Rheumatic Diseases: A Narrative Literature ReviewNathan Karp, Jinoos Yazdany, Gabriela SchmajukSeminars in Arthritis and Rheumatism|August 31, 2015
Factors associated with access to rheumatologists for Medicare patientsGabriela Schmajuk, Chris Tonner, Jinoos YazdanySeminars in Arthritis and Rheumatism|November 16, 2024
Promises and pitfalls of artificial intelligence models in forecasting rheumatoid arthritis treatment response and outcomesAugusto Garcia-Agundez, Gabriela Schmajuk, Jinoos YazdanyRheumatology International|December 7, 2017
The impact of smoking on disease measures in rheumatoid arthritis: the need for appropriate adjustment of time-varying confoundingMilena A Gianfrancesco, Jinoos Yazdany, Gabriela SchmajukArthritis Care & Research|August 9, 2013
Patterns of disease-modifying antirheumatic drug use in rheumatoid arthritis patients after 2002: a systematic reviewGabriela Schmajuk, Daniel H Solomon, Jinoos YazdanyPageof 15